Actos, Pioglitazone


Add to MyYahoo RSS

Actos, Pioglitazone News

News on Actos, Pioglitazone (generic) continually updated from thousands of sources around the net.

16 hrs ago | Chemistry World

$10bn mismarketing fine for Takeda and Lilly

Japan's Takeda Pharmaceuticals and its US partner Eli Lilly have been ordered by a US jury to pay a record $10.5 billion in damages concerning mis-marketing of diabetes drug Actos .


Related Topix: Medicine, Marketing

Thu Apr 17, 2014

Business Journal

Scripps scientists win $2M research grant

The National Institutes of Health provided the five-year grant to a team led by Douglas Kojetin , an associate professor.


Related Topix: Medicine, Health, Diabetes, Avandia, Rosiglitazone (generic)

Wed Apr 16, 2014


Islet Sciences Announces Positive 12-Week Phase 2 Clinical Results...

Islet Sciences, Inc. and BHV Pharma today announced positive results from two 12-week phase 2b clinical studies of remogliflozin etabonate in type 2 diabetics.


Related Topix: Medicine


Scientists awarded $2 million to study improvements in anti-diabetic drug design

Scientists from the Florida campus of The Scripps Research Institute have been awarded $2.1 million from the National Institutes of Health to study the therapeutic potential of safer and more effective alternatives to the current crop of anti-diabetic drugs, which have been limited in their use due to side effects including bone loss and congestive ... (more)


Related Topix: Scripps Research Institute, Technical Services, Medicine, Heart Failure, Health, Diabetes, Avandia, Rosiglitazone (generic)

Tue Apr 15, 2014

KLAS-TV Las Vegas

Plaintiff in drug trial tells jury her story

For the first time, in front of a jury, one of the local women suing a major drug company told her story of how she was diagnosed with cancer after taking a medication meant to treat diabetes.


Related Topix: Healthcare Law, Law, Medicine, Diabetes, Health

FDA Approves New Type 2 Diabetes Drug

TUESDAY April 15, 2014, 2014 -- Millions of Americans with type 2 diabetes have a new treatment option with the U.S. Food and Drug Administration's approval Tuesday of a once-weekly injectable drug, Tanzeum.


Related Topix: Food and Drug Administration, Medicine, Diabetes, Health, Thyroid Cancer

Thu Apr 10, 2014

Big News

Takeda and Eli Lilly to appeal $9bn punitive damages ordered by court

Our eNewspaper network was founded in 2002 to provide stand-alone digital news sites tailored for the most searched-for locations for news.


Related Topix: Biotech, Medicine, Eli Lilly, Healthcare Industry, Diabetes, Health, bladder cancer

Wed Apr 09, 2014

Lupin gets USFDA approval for diabetes management drug

Lupin said its US subsidiary, Lupin Pharmaceuticals Inc has received final approval for its Pioglitazone tablets from the US Food and Drugs Administration to market generic version of Takeda Pharmaceuticals USA Inc's Actos tablets.


Related Topix: Medicine, Health, Diabetes

Tue Apr 08, 2014

Huge Punitive Damages Award in Actos Bellwether Trial

A jury in Louisiana has awarded more than $9 billion in the first federal bellwether trial over claims that taking Actos increases the risk of getting bladder cancer.


Related Topix: Healthcare Law, Law, Medicine, Biotech, Eli Lilly, Healthcare Industry

The Standard

Japana s Takeda to appeal US$6b diabetes drug verdict

A US jury ordered Japan's Takeda Pharmaceuticals to pay US$6 billion in punitive damages over a diabetes drug, but the country's biggest drug-maker is challenging the move.


Related Topix: Medicine, Health, Diabetes


Japan drugmaker Takeda says will fight $6.0 bn US damages order

Japan's biggest drugs maker Takeda Pharmaceutical said Tuesday it would fight a huge $6.0 billion damages order imposed by a US jury following a trial over the safety of its Actos diabetes medicine.


Related Topix: Medicine, Diabetes, Health, bladder cancer

Business Wire

Fitch: Lilly's Ratings Intact Following $9B Actos Jury Verdict

Fitch rates LLY 'A' and the Rating Outlook is Stable. The U.S. district court in Louisiana this week rendered a $6 billion judgment against Takeda and a $3 billion penalty against LLY stemming from allegations that their Actos diabetes medicine is linked to bladder cancer.


Related Topix: Medicine, Biotech, Eli Lilly, Healthcare Industry, Diabetes, Health

Japan's Topix declines for third day

Japan's Topix index fell for a third day, posting its biggest decline in three weeks, as the yen strengthened and health-care and Internet stocks tumbled.


Related Topix: Financial Markets, Medicine, Diabetes, Health

The Washington Post

Asian Stocks Decline Second Day as Health-Care, Tech Shares Drop

Asian stocks fell for a second day, following the biggest three-day rout in U.S. shares in more than two months, as health-care to technology companies retreated in Japan.


Related Topix: Financial Markets, Medicine, Diabetes, Health, Yahoo! Japan, Science / Technology

Mon Apr 07, 2014


Actos Verdict: Jury Orders Takeda, Eli Lilly To Pay $9 Billion In Damages

A picture taken on June 9, 2011 outside a pharmacy of the northern city of Lille, shows a pack of Actos antidiabetic drugs .


Related Topix: Medicine, Biotech, Eli Lilly, Healthcare Industry, Diabetes, Health, Life, Food, Nutrition, Fruits


Takeda Loses First Federal Trial Over Actos Diabetes Drug

Takeda Pharmaceutical Co. lost the first federal court trial in the U.S. over claims it hid the cancer risks of its Actos diabetes medicine to protect billions of dollars in sales.


Related Topix: Medicine, Lafayette, LA

Thu Apr 03, 2014

BioMed Central

Utilisation trends of rosiglitazone and pioglitazone in Australia before and after safety warnings

A series of drug safety warnings have recently been made by drug authorities relating to adverse effects of rosiglitazone and pioglitazone on cardiovascular diseases and bladder cancer.


Related Topix: Avandia, Rosiglitazone (generic), Medicine, Food and Drug Administration